Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown
- 30 September 1992
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3), 197-201
- https://doi.org/10.1016/0960-0760(92)90208-z
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Controversies in the management of localised and metastatic prostatic cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- R 75251, a new inhibitor of steroid biosynthesisThe Prostate, 1990
- Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in ratsThe Prostate, 1990
- Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-promoted tumor formation in CD-1 and Sencar miceCancer Letters, 1988
- Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cellsBiochemical Pharmacology, 1987
- Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR miceCancer Letters, 1986
- History of retinoidsJournal of the American Academy of Dermatology, 1982
- Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endodermCell, 1976